의료기기 커프 시장 규모, 점유율, 동향 분석 보고서 : 유형별, 최종 용도별, 지역별, 부문 예측(2025-2030년)

Medical Devices Cuffs Market Growth & Trends:

The global medical devices cuffs market size is expected to reach USD 1217.6 million by 2030, registering a CAGR of 4.25% from 2025 to 2030, according to a new report by Grand View Research, Inc. The increasing geriatric population, technological advancements, and rising prevalence of cardiovascular diseases, and respiratory disorders and diseases are the key factors driving the market.

Cardiovascular diseases (CVDs) have become one of the major causes of mortality and morbidity in the world during the last three decades. Coronary artery disease, arrhythmias, peripheral vascular disease, and congenital heart defects are the major cardiovascular diseases that are prevalent across the globe. According to the report published by the American Heart Association in 2018, around 92.1 million Americans were living with some form of CVD, which is the most common cause of mortality in the country as compared to cancer and other chronic diseases. It also reported that around 2,300 Americans die due to cardiovascular disease per day, which is around 1 death in every 38 seconds.

Similarly, as per the report published by the World Atlas, Russia has the highest prevalence of CVD, which is around 57.0% of the mortality cases in the country. The increasing number of patients suffering from hypertension and high blood pressure are the major factors for the increasing prevalence of cardiovascular diseases. In cases of hypertension, cardiovascular diseases, and high blood pressure, blood pressure monitoring devices are one of the essential requirements for the treatment and diagnosis.

The increasing adoption of a sedentary lifestyle has also propelled the prevalence rate of various types of CVDs across the globe. Physical inactivity, smoking, high blood pressure, and obesity are some of the major factors boosting the CVDs rate. For instance, as per the American Heart Association, about 30.4% of the U.S. adults do not engage in physical activity. Therefore, such factors are anticipated to propel market growth over the forecast period.

Medical Devices Cuffs Market Report Highlights:

• The blood pressure cuffs segment captured the largest revenue share of over 45.6% in 2024. The cuffed endotracheal tube segment is expected to witness the fastest CAGR over the forecast period.
• The hospitals segment captured the largest revenue share in 2024 due to their high patient footfall and extensive use of monitoring and therapeutic devices.
• The ambulatory surgical centers segment is anticipated to witness a significant CAGR over the forecast period due to their increasing adoption of non-invasive monitoring and post-operative care solutions.
• North America medical devices cuffs market dominated globally in 2024 with the largest revenue share of 35.93%. The medical device cuffs industry in the U.S. held the largest share in North America in 2024, driven by the increasing prevalence of chronic diseases and the ongoing evolution of healthcare technologies.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Type
  • 1.2.2. End Use
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. Gvr's Internal Database
  • 1.4.3. Secondary Sources
  • 1.4.4. Primary Research
  • 1.4.5. Details of primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.1.1. Approach 1: Commodity flow approach
  • 1.7.2. Volume price analysis (Model 2)
    • 1.7.2.1. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Regional outlook
• 2.4. Competitive Insights

Chapter 3. Medical Device Cuffs Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Growing prevalence of cardiovascular diseases
    • 3.2.1.2. Increase in geriatric population across the globe
    • 3.2.1.3. Increasing demand for home care services
    • 3.2.1.4. Increasing adoption of sedentary lifestyles
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Issues related to product approval and commercialization
    • 3.2.2.2. Lack of knowledge towards medical devices cuffs in developing and underdeveloped countries
  • 3.2.3. Market Challenges Analysis
  • 3.2.4. Market Oppurtunities Analysis
• 3.3. Medical Device Cuffs Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape
  • 3.3.3. Market Entry Strategies

Chapter 4. Medical Device Cuffs Market: Type Estimates & Trend Analysis

• 4.1. Definitions and Scope
• 4.2. Type Market Share, 2018 & 2030
• 4.3. Segment Dashboard
• 4.4. Medical Device Cuffs Market by Type Outlook
• 4.5. Market Size & Forecasts and Trend Analysis, 2025 to 2030 for the following:
  • 4.5.1. Blood Pressure Cuffs
    • 4.5.1.1. Blood pressure cuffs market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5.2. Cuffed Endotracheal Tube
    • 4.5.2.1. Cuffed endotracheal tube market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5.3. Tracheostomy tube
    • 4.5.3.1. Tracheostomy tube market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Medical Device Cuffs Market: End Use Estimates & Trend Analysis

• 5.1. Definitions and Scope
• 5.2. End Use Market Share, 2018 & 2030
• 5.3. Segment Dashboard
• 5.4. Medical Device Cuffs Market by End Use Outlook
• 5.5. Market Size & Forecasts and Trend Analysis, 2025 to 2030 for the following:
  • 5.5.1. Hospital
    • 5.5.1.1. Hospital market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5.2. Clinics
    • 5.5.2.1. Clinics market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5.3. Ambulatory Surgery Centers
    • 5.5.3.1. Ambulatory surgery centers market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5.4. Other
    • 5.5.4.1. Other market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Medical Device Cuffs Market: Regional Estimates & Trend Analysis, By Type. By End Use

• 6.1. Regional market share analysis, 2024 & 2030
• 6.2. Regional Market Dashboard
• 6.3. Global Regional Market Snapshot
• 6.4. Regional Market Share and Leading Players, 2024
  • 6.4.1. North America
  • 6.4.2. Europe
  • 6.4.3. Asia Pacific
  • 6.4.4. Latin America
  • 6.4.5. Middle East and Africa
• 6.5. Market Application, & Forecasts and Trend Analysis, 2018 to 2030:
• 6.6. North America
  • 6.6.1. Market estimates and forecast, 2018 -2030 (Revenue, USD Million)
  • 6.6.2. U.S.
    • 6.6.2.1. Key country dynamics
    • 6.6.2.2. Competitive scenario
    • 6.6.2.3. Regulatory framework
    • 6.6.2.4. Reimbursement scenario
    • 6.6.2.5. U.S. market estimates and forecasts, 2018 -2030
  • 6.6.3. Canada
    • 6.6.3.1. Key country dynamics
    • 6.6.3.2. Competitive scenario
    • 6.6.3.3. Regulatory framework
    • 6.6.3.4. Reimbursement scenario
    • 6.6.3.5. Canada market estimates and forecasts, 2018 -2030
  • 6.6.4. Mexico
    • 6.6.4.1. Key country dynamics
    • 6.6.4.2. Competitive scenario
    • 6.6.4.3. Regulatory framework
    • 6.6.4.4. Reimbursement scenario
    • 6.6.4.5. Mexico market estimates and forecasts, 2018 -2030
• 6.7. Europe
  • 6.7.1. UK
    • 6.7.1.1. Key country dynamics
    • 6.7.1.2. Competitive scenario
    • 6.7.1.3. Regulatory framework
    • 6.7.1.4. Reimbursement scenario
    • 6.7.1.5. UK market estimates and forecasts, 2018 -2030
  • 6.7.2. Germany
    • 6.7.2.1. Key country dynamics
    • 6.7.2.2. Competitive scenario
    • 6.7.2.3. Regulatory framework
    • 6.7.2.4. Reimbursement scenario
    • 6.7.2.5. Germany market estimates and forecasts, 2018 -2030
  • 6.7.3. France
    • 6.7.3.1. Key country dynamics
    • 6.7.3.2. Competitive scenario
    • 6.7.3.3. Regulatory framework
    • 6.7.3.4. Reimbursement scenario
    • 6.7.3.5. France market estimates and forecasts, 2018 -2030
  • 6.7.4. Italy
    • 6.7.4.1. Key country dynamics
    • 6.7.4.2. Competitive scenario
    • 6.7.4.3. Regulatory framework
    • 6.7.4.4. Reimbursement scenario
    • 6.7.4.5. Italy market estimates and forecasts, 2018 -2030
  • 6.7.5. Spain
    • 6.7.5.1. Key country dynamics
    • 6.7.5.2. Competitive scenario
    • 6.7.5.3. Regulatory framework
    • 6.7.5.4. Reimbursement scenario
    • 6.7.5.5. Spain market estimates and forecasts, 2018 -2030
  • 6.7.6. Denmark
    • 6.7.6.1. Key country dynamics
    • 6.7.6.2. Competitive scenario
    • 6.7.6.3. Regulatory framework
    • 6.7.6.4. Reimbursement scenario
    • 6.7.6.5. Denmark market estimates and forecasts, 2018 -2030
  • 6.7.7. Sweden
    • 6.7.7.1. Key country dynamics
    • 6.7.7.2. Competitive scenario
    • 6.7.7.3. Regulatory framework
    • 6.7.7.4. Reimbursement scenario
    • 6.7.7.5. Sweden market estimates and forecasts, 2018 -2030
  • 6.7.8. Norway
    • 6.7.8.1. Key country dynamics
    • 6.7.8.2. Competitive scenario
    • 6.7.8.3. Regulatory framework
    • 6.7.8.4. Reimbursement scenario
    • 6.7.8.5. Norway market estimates and forecasts, 2018 -2030
• 6.8. Asia Pacific
  • 6.8.1. Japan
    • 6.8.1.1. Key country dynamics
    • 6.8.1.2. Competitive scenario
    • 6.8.1.3. Regulatory framework
    • 6.8.1.4. Reimbursement scenario
    • 6.8.1.5. Japan market estimates and forecasts, 2018 -2030
  • 6.8.2. India
    • 6.8.2.1. Key country dynamics
    • 6.8.2.2. Competitive scenario
    • 6.8.2.3. Regulatory framework
    • 6.8.2.4. Reimbursement scenario
    • 6.8.2.5. India market estimates and forecasts, 2018 -2030
  • 6.8.3. China
    • 6.8.3.1. Key country dynamics
    • 6.8.3.2. Competitive scenario
    • 6.8.3.3. Regulatory framework
    • 6.8.3.4. Reimbursement scenario
    • 6.8.3.5. China market estimates and forecasts, 2018 -2030
  • 6.8.4. South Korea
    • 6.8.4.1. Key country dynamics
    • 6.8.4.2. Competitive scenario
    • 6.8.4.3. Regulatory framework
    • 6.8.4.4. Reimbursement scenario
    • 6.8.4.5. South Korea market estimates and forecasts, 2018 -2030
  • 6.8.5. Australia
    • 6.8.5.1. Key country dynamics
    • 6.8.5.2. Competitive scenario
    • 6.8.5.3. Regulatory framework
    • 6.8.5.4. Reimbursement scenario
    • 6.8.5.5. Australia market estimates and forecasts, 2018 -2030
  • 6.8.6. Thailand
    • 6.8.6.1. Key country dynamics
    • 6.8.6.2. Competitive scenario
    • 6.8.6.3. Regulatory framework
    • 6.8.6.4. Reimbursement scenario
    • 6.8.6.5. Thailand market estimates and forecasts, 2018 -2030
• 6.9. Latin America
  • 6.9.1. Brazil
    • 6.9.1.1. Key country dynamics
    • 6.9.1.2. Competitive scenario
    • 6.9.1.3. Regulatory framework
    • 6.9.1.4. Reimbursement scenario
    • 6.9.1.5. Brazil market estimates and forecasts, 2018 -2030
  • 6.9.2. Argentina
    • 6.9.2.1. Key country dynamics
    • 6.9.2.2. Competitive scenario
    • 6.9.2.3. Regulatory framework
    • 6.9.2.4. Reimbursement scenario
    • 6.9.2.5. Argentina market estimates and forecasts, 2018 -2030
• 6.10. MEA
  • 6.10.1. South Africa
    • 6.10.1.1. Key country dynamics
    • 6.10.1.2. Competitive scenario
    • 6.10.1.3. Regulatory framework
    • 6.10.1.4. Reimbursement scenario
    • 6.10.1.5. South Africa market estimates and forecasts, 2018 -2030
  • 6.10.2. Saudi Arabia
    • 6.10.2.1. Key country dynamics
    • 6.10.2.2. Competitive scenario
    • 6.10.2.3. Regulatory framework
    • 6.10.2.4. Reimbursement scenario
    • 6.10.2.5. Saudi Arabia market estimates and forecasts, 2018 -2030
  • 6.10.3. UAE
    • 6.10.3.1. Key country dynamics
    • 6.10.3.2. Competitive scenario
    • 6.10.3.3. Regulatory framework
    • 6.10.3.4. Reimbursement scenario
    • 6.10.3.5. UAE market estimates and forecasts, 2018 -2030
  • 6.10.4. Kuwait
    • 6.10.4.1. Key country dynamics
    • 6.10.4.2. Competitive scenario
    • 6.10.4.3. Regulatory framework
    • 6.10.4.4. Reimbursement scenario
    • 6.10.4.5. Kuwait market estimates and forecasts, 2018 -2030

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Market Participants
• 7.2. Company/Competition Categorization
  • 7.2.1. Innovators
• 7.3. Vendor Landscape
  • 7.3.1. List of key distributors and channel partners
  • 7.3.2. Key customers
  • 7.3.3. Key company market share analysis, 2024
  • 7.3.4. Medtronic plc
    • 7.3.4.1. Company overview
    • 7.3.4.2. Financial performance
    • 7.3.4.3. Product benchmarking
    • 7.3.4.4. Strategic initiatives
  • 7.3.5. Smith's Medical (Smiths Group plc)
    • 7.3.5.1. Company overview
    • 7.3.5.2. Financial performance
    • 7.3.5.3. Product benchmarking
    • 7.3.5.4. Strategic initiatives
  • 7.3.6. Teleflex Incorporated
    • 7.3.6.1. Company overview
    • 7.3.6.2. Financial performance
    • 7.3.6.3. Product benchmarking
    • 7.3.6.4. Strategic initiatives
  • 7.3.7. ConvaTec Inc.
    • 7.3.7.1. Company overview
    • 7.3.7.2. Financial performance
    • 7.3.7.3. Product benchmarking
    • 7.3.7.4. Strategic initiatives
  • 7.3.8. Cook Medical (Cook Group Incorporated)
    • 7.3.8.1. Company overview
    • 7.3.8.2. Financial performance
    • 7.3.8.3. Product benchmarking
    • 7.3.8.4. Strategic initiatives
  • 7.3.9. Troge Medical GmbH
    • 7.3.9.1. Company overview
    • 7.3.9.2. Financial performance
    • 7.3.9.3. Product benchmarking
    • 7.3.9.4. Strategic initiatives
  • 7.3.10. Fuji Systems Corporation
    • 7.3.10.1. Company overview
    • 7.3.10.2. Financial performance
    • 7.3.10.3. Product benchmarking
    • 7.3.10.4. Strategic initiatives
  • 7.3.11. Well Lead Medical Co., Ltd.
    • 7.3.11.1. Company overview
    • 7.3.11.2. Financial performance
    • 7.3.11.3. Product benchmarking
    • 7.3.11.4. Strategic initiatives
  • 7.3.12. TRACOE medical GmbH
    • 7.3.12.1. Company overview
    • 7.3.12.2. Financial performance
    • 7.3.12.3. Product benchmarking
    • 7.3.12.4. Strategic initiatives
  • 7.3.13. Pulmodyne, Inc.
    • 7.3.13.1. Company overview
    • 7.3.13.2. Financial performance
    • 7.3.13.3. Product benchmarking
    • 7.3.13.4. Strategic initiatives